ProfileGDS4718 / 1561500_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 60% 57% 64% 63% 54% 57% 62% 62% 59% 56% 62% 63% 61% 56% 52% 58% 59% 58% 71% 57% 56% 58% 59% 58% 57% 59% 53% 65% 65% 61% 52% 64% 58% 54% 56% 64% 58% 58% 53% 57% 66% 58% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2962863
GSM549102patient 115, normal, homogenized [OPG study]6.1484560
GSM549104patient 119, normal, homogenized [OPG study]5.9277757
GSM549108patient 138, normal, homogenized [OPG study]6.3870864
GSM549119patient 077, normal, homogenized [OPG study]6.3229963
GSM549133patient 032, cancer, homogenized [OPG study]5.7000554
GSM549139patient 042, cancer, homogenized [OPG study]5.8896557
GSM549099patient 107, normal, homogenized [OPG study]6.262962
GSM549109patient 139, normal, homogenized [OPG study]6.2827962
GSM549110patient 046, normal, homogenized [OPG study]6.043459
GSM549114patient 063, normal, homogenized [OPG study]5.8106656
GSM549122patient 082, normal, homogenized [OPG study]6.319662
GSM549134patient 033, cancer, homogenized [OPG study]6.3389963
GSM549136patient 036, cancer, homogenized [OPG study]6.1535361
GSM549140patient 044, cancer, homogenized [OPG study]5.8465556
GSM549111patient 047, normal, homogenized [OPG study]5.6391752
GSM549113patient 057, normal, homogenized [OPG study]5.9427658
GSM549132patient 031, cancer, homogenized [OPG study]6.0508959
GSM549137patient 038, cancer, homogenized [OPG study]5.9687658
GSM549142patient 047, cancer, homogenized [OPG study]6.9011371
GSM549100patient 110, normal, homogenized [OPG study]5.9481257
GSM549107patient 135, normal, homogenized [OPG study]5.8513556
GSM549115patient 068, normal, homogenized [OPG study]5.9928358
GSM549116patient 072, normal, homogenized [OPG study]6.0498359
GSM549120patient 078, normal, homogenized [OPG study]5.9732158
GSM549131patient 030, cancer, homogenized [OPG study]5.8818657
GSM549118patient 074, normal, homogenized [OPG study]6.0456759
GSM549129patient 027, cancer, homogenized [OPG study]5.7201253
GSM549123patient 088, normal, homogenized [OPG study]6.5018465
GSM549124patient 006, cancer, homogenized [OPG study]6.4839965
GSM549126patient 015, cancer, homogenized [OPG study]6.1768761
GSM549128patient 025, cancer, homogenized [OPG study]5.6376852
GSM549103patient 117, normal, homogenized [OPG study]6.376164
GSM549117patient 073, normal, homogenized [OPG study]5.9470558
GSM549138patient 041, cancer, homogenized [OPG study]5.7445554
GSM549141patient 045, cancer, homogenized [OPG study]5.8145856
GSM549130patient 028, cancer, homogenized [OPG study]6.4086264
GSM549101patient 111, normal, homogenized [OPG study]6.0382458
GSM549105patient 128, normal, homogenized [OPG study]6.0291958
GSM549106patient 134, normal, homogenized [OPG study]5.6393753
GSM549112patient 048, normal, homogenized [OPG study]5.9053557
GSM549125patient 011, cancer, homogenized [OPG study]6.5566366
GSM549127patient 024, cancer, homogenized [OPG study]6.0273658
GSM549135patient 035, cancer, homogenized [OPG study]5.689353